Facebook
Instagram
Pinterest
Reddit
Tumblr
Twitter
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 234
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Melissa Lavasani & Jay Kopelman: Federal Psychedelic Policy, VA Pathways, and Ibogaine Safety Standards
Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts
Couples Are Turning to Ketamine-Assisted Therapy to Heal Their Relationships
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
MYND Life Sciences Announces $3 Million Convertible Debenture Unit Offering
MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital...
Silo Pharma Advances Psychedelic Patent Portfolio
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to...
Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon...
Microdosing LSD Makes Me a Better Mom
Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling...
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the...
Same But Different: Antidepressant Mechanisms of Psilocybin and Ketamine
Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent...
1
...
233
234
235
...
308
Page 234 of 308